FOXO1 and Hyperglycemia: In the present study, FoxO1 was consistently found to be highly expressed in carotid arteries, accompanied by hyperglycaemia‐induced vascular remodelling, while FoxO1 inhibitor ameliorated the hyperglycaemia‐induced SMCs decrease in carotid medium of type 1 diabetic rats.